US-based DermaSensor has announced a newly published study showing that its AI-powered device can improve a primary care physician’s ability to assess moles of concern. In the prospective study, ...

The advanced development of medical technology has accelerated in recent years, with devices being continuously manufactured for healthcare professionals as well as consumers at home. From wellbeing ...

MIAMI--(BUSINESS WIRE)--DermaSensor Inc., a health technology company designing non-invasive tools to better equip primary care physicians for skin cancer detection, today announced the publication of ...

Innovative Skin Cancer Detection Device Transforming Patient Care in Physician Offices Throughout U.S. The FDA Cleared, CE Marked DermaSensor device enables physicians to non-invasively provide ...

Please provide your email address to receive an email when new articles are posted on . The device is a handheld tool that uses spectroscopy and algorithms to test worrisome skin lesions for cancer.

Cody Simmons is CEO of DermaSensor, a Miami-based health-tech startup that is developing a medical device that aims to detect the risk of skin cancer. A user would scan a mole or lesion with the ...

The DermaSensor device is an affordable, handheld device that uses machine learning and spectroscopy to automatically test skin lesions for potential cancer. DermaSensor's optical spectroscopy and ...

EINPresswire/ -- DermaSensor Inc., a medical device technology company transforming skin cancer detection for frontline care, today announced it has raised $16 million in Series B funding to fuel the ...

BOSTON - One in five Americans will develop skin cancer in their lifetime but it can be hard to tell the difference between a benign mole and cancer during a routine. Now, a new AI-powered device ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The Florida native leads a ...